"Excipients" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc.
| Descriptor ID |
D005079
|
| MeSH Number(s) |
D26.650.700.419 D27.720.744.770.419
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Excipients".
Below are MeSH descriptors whose meaning is more specific than "Excipients".
This graph shows the total number of publications written about "Excipients" by people in this website by year, and whether "Excipients" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Excipients" by people in Profiles.
-
Sattler S, Gollomp S, Curry A. A Narrative Literature Review of the Established Safety of Human Serum Albumin Use as a Stabilizer in Aesthetic Botulinum Toxin Formulations Compared to Alternatives. Toxins (Basel). 2023 10 18; 15(10).
-
Morales AM, Sreedhara A, Buecheler J, Brosig S, Chou D, Christian T, Das T, de Jong I, Fast J, Jagannathan B, Moussa EM, Nejadnik MR, Prajapati I, Radwick A, Rahman Y, Singh S. End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics. AAPS J. 2022 12 05; 25(1):6.
-
Shin Y, Kokate R, Desai V, Bhushan A, Kaushal G. D-cycloserine nasal formulation development for anxiety disorders by using polymeric gels. Drug Discov Ther. 2018; 12(3):142-153.
-
Thakral NK, Behme RJ, Aburub A, Peterson JA, Woods TA, Diseroad BA, Suryanarayanan R, Stephenson GA. Salt Disproportionation in the Solid State: Role of Solubility and Counterion Volatility. Mol Pharm. 2016 12 05; 13(12):4141-4151.
-
Cushing DJ, Souney PF, Cooper WD, Mosher GL, Adams MP, Machatha S, Zhang B, Kowey PR. Pharmacokinetics and platelet aggregation inhibitory effects of a novel intravenous formulation of clopidogrel in humans. Clin Exp Pharmacol Physiol. 2012 Jan; 39(1):3-8.
-
Shoyele SA, Sivadas N, Cryan SA. The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation. AAPS PharmSciTech. 2011 Mar; 12(1):304-11.
-
Cushing DJ, Kowey PR, Cooper WD, Massey BW, Gralinski MR, Lipicky RJ. PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects. Eur J Pharmacol. 2009 Apr 01; 607(1-3):167-72.
-
Shoyele SA. Engineering protein particles for pulmonary drug delivery. Methods Mol Biol. 2008; 437:149-60.